MedPath

A Cost Effectiveness Analysis of Robotic Versus Laparoscopic Distal Pancreatectomy

Completed
Conditions
Surgery
Interventions
Device: Da Vinci
Registration Number
NCT03989739
Lead Sponsor
Fundación de investigación HM
Brief Summary

This is a clinical and cost-effectiveness analysis within a retrospective comparative study of RDP and LDP conducted at Sanchinarro University Hospital from 2011 to 2017. Outcome parameters included surgical and post-operative costs, quality adjusted life years (QALY), and incremental cost per QALY gained or the incremental cost effectiveness ratio (ICER). A sensitivity analysis was carried out in order to propagate the uncertainty of the estimations to the results of the model. The investigators use a multivariate and stochastic sensitivity analysis performed by 5000 Monte Carlo simulations. The cost-effectiveness plane was used to represent all pairs of solutions of the model.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Patients (aged over 18 years) with benign or malignant mass without evidence of major vessel involvement were included.
  • The indication for resection was given in the context of a multidisciplinary institutional committee
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
robotic distal pancreatectomyDa Vinci-
Primary Outcome Measures
NameTimeMethod
Costs2014-2018

Direct costs

Quality-adjusted life years2014-2018

Quality-adjusted life years

ICER2014-2018

Incremental Cost-effectiveness Ratio

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath